Watson Confirms Simcor Patent Challenge

Watson Pharmaceuticals Wednesday confirmed that its subsidiary, Watson Laboratories- Florida, filed an Abbreviated New Drug Application with the FDA seeking approval to market its 1000 mg/20 mg form of niacin extended-release/simvastatin tablets.
Benzinga